DPT Laboratories defines newly-expanded sterile pharmaceutical manufacturing capabilities at its Center of Excellence in Lakewoo

DPT Laboratories defines newly-expanded sterile pharmaceutical manufacturing capabilities at its Center of Excellence in Lakewood, N.J.
LAKEWOOD, N.J.--(BUSINESS WIRE)--DPT Laboratories, Ltd., a pharmaceutical contract development and manufacturing organization, announced today additional details on the expansion of its aseptic manufacturing and development capabilities at its Center of Excellence for Sterile & Specialty Products in Lakewood, N.J.

"This is truly a state-of-the-art site with some of the best equipment and newest suites in the industry"
.Building on its reputation as the industry leader for semi-solids and liquids, DPT's sterile center will focus on aseptic production of sterile dosage forms to include small-volume parenterals, ophthalmic preparations, preservative-free nasal sprays and sterile ointments.

"This is truly a state-of-the-art site with some of the best equipment and newest suites in the industry," said Gene Ciolfi, DPT's general manager for Sterile & Specialty Products.

DPT has invested more than $30 million in infrastructure to enhance the 175,000-square-foot center. Some of the investments include new water for injection, clean steam and HVAC systems, as well as a state-of-the-art microbiology laboratory. The new micro lab provides comprehensive in-house microbiology testing services such as environmental monitoring, sterility testing using isolation technology, and endotoxin testing. The center is also equipped with pharmaceutical clean room assets that include Class A filling suites, Class B & C support suites and Class D component preparation areas.

"Not only did we invest in the facility, but we also hired the right individuals who are experts in this field," Ciolfi added. "Our employees will leverage their expertise combined with the company's 70-year history to provide our customers with quality services."

In addition to the personnel onsite, this center will be supported by DPT's Center of Excellence for Research & Development in San Antonio for pre-formulation and formulation development activities as well as analytical development services and technology transfers. DPT has more than 1,000 employees, including more than 100 scientists and engineers.

"The industry is ready for a service provider who is focused on providing solutions for clinical, small-lot, and large scale sterile manufacturing needs," said JJ Feik, Director of Marketing and Corporate Development for DPT. "I believe with our combined reputation for expertise, quality, service, and regulatory compliance, we are a logical choice for contract sterile manufacturing and development services."

About DPT Laboratories

DPT, a DFB company, is a contract development and manufacturing organization (CDMO) providing companies the best solutions to their sterile and non-sterile pharmaceutical development and manufacturing needs through innovation, technology, and service. Specializing in semi-solid and liquid dosage forms, DPT has a reputation for quality, unmatched technical expertise, extensive manufacturing capabilities, and an exemplary regulatory compliance record. With five cGMP facilities in San Antonio and Lakewood, N.J., DPT offers full service outsourcing solutions including stand alone development, site transfers, state-of-the-art manufacturing, packaging, and worldwide distribution. For more information, call 210-476-8100 or visit www.DPTLabs.com.


Contacts
DPT Laboratories
Stacy London, 210-396-5008

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.